Dotbee.ai

Analysis Healios K.K. (4593)

5/27/2024

Analysis Healios K.K. (4593)

Analysis of Healios K.K. (4593)

Healios K.K. (4593) has been showing a downward trend in the stock price over the past few days. The Relative Strength Index (RSI) is indicating that the stock is approaching oversold levels, currently at 30.51, suggesting a possible reversal in the near future.

The Moving Average Convergence Divergence (MACD) indicator is negative, with the MACD line below the signal line and the histogram showing a decreasing trend. This indicates a bearish momentum in the stock price.

The Moving Average (MA) indicator is also showing a downward trend, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) all below the current stock price.

Overall, based on the technical indicators, Healios K.K. may experience further downward movement in the stock price in the short term. Traders and investors should closely monitor the RSI for any signs of a potential reversal in the stock price trend.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.

In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.

Moving on to stock statistics, the company has a short ratio of 1.66, with 15.31 billion float shares and 94.31 million shares shorted. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.55% held by institutions.

Valuation metrics show a PEG ratio of 26.21, forward PE of 26.21, and trailing PE of 29.43. The enterprise value is $2.95 trillion, with a price to book ratio of 39.18 and price to sales ratio of 7.62. The enterprise to EBITDA ratio is 22.75 and the enterprise to revenue ratio is 7.73. The market capitalization is $2.91 trillion.

The stock price summary includes a beta of 1.26, a 50-day moving average of $173.69, a 200-day moving average of $180.79, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 8.25%.

Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential challenge in managing production or procurement costs.
3. The gross profit margin has fluctuated slightly but remained relatively stable over the years.
4. Operating income has shown an increasing trend, reaching $114.3 billion in 2023.
5. Net income has also been on the rise, reaching $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a healthy EBITDA margin, indicating efficient operational performance.
8. The company has been able to effectively manage its income tax expenses over the years.
9. Overall, the financial performance of the company in terms of revenue and profitability has shown positive growth trends.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements, reflecting a focus on long-term growth.
7. There is a consistent level of short-term debt and accounts payable, indicating stable financial obligations.
8. Retained earnings have fluctuated over the years, impacting the overall shareholders' equity.
9. The company has been managing risks and charges through provisions in the balance sheet.
10. Overall, the financial health of the company seems stable and growing steadily.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Number of Analysts: 26
- Year Ago EPS: $1.26

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Number of Analysts: 25
- Year Ago EPS: $1.46

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Number of Analysts: 39
- Year Ago EPS: $6.13

4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Number of Analysts: 39
- Year Ago EPS: $6.59

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two fiscal years. It indicates growth in earnings compared to the previous year, with the highest estimates for the next year.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates indicate a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.

Growth estimates

Based on the consensus estimates provided:
- The company is expected to have a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is expected to be 4.8%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of 11%.
- However, when comparing to the past 5 years, where the company had a CAGR of 20.15%, the growth rate is expected to slow down in the upcoming years.

These estimates suggest that the company is expected to continue growing, albeit at a slightly slower pace compared to the past.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.

MACD of 4593

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link